Our previous studies found that TGF-β1 increased the deposition of FBLN-1 in asthmatic ASM cells only within 24 hours [13], and TGF-β1 increased the deposition of perlecan in COPD ASM cells only following 48 hours stimulation [22]. Here, FBLN1 is linked to chronic obstructive pulmonary disease.